6-(2,6-Dimethylmorpholin-4-yl)pyridine-3-carboxylic acid, 98%, 1g

1-(4,5-Dihydrothiazol-2-yl)azetidine-3-thiol hydrochloride, 95.0%, 25g

Hexane (isomers), min. 95% (isomers), for synthesis, 5 l, alu

1-(tert-Butyl) 2-methyl (R)-4-oxopiperidine-1,2-dicarboxylate, 98%, 10g

2-Cyano-5-nitrobenzotrifluoride, 98.0%, 5g

8-Methoxy-2,3,4,5-tetrahydro-benzo[c]azepin-1-one, 98.0%, 5g

BCA, 100g

2,6-Dibromo-4-(difluoromethoxy)aniline, 98.0%, 25g

(E)-4-(2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)vinyl)phenol, 100mg

D-Phenylalanine, N-[N-[(1,1-dimethylethoxy)carbonyl]-L-leucyl]-, phenylmethyl ester, 98%, 100mg

4-[2,2,2-Trifluoro-1-[(trimethylsilyl)oxy]ethyl]morpholine>95.0%(GC)5g

(3S,5R)-TERT-BUTYL 3-AMINO-5-METHYLPIPERIDINE-1-CARBOXYLATE, 95.0%, 1g

4,6-Dibromo-3-hydroxypicolinonitrile, 98%, 10g